Skip to main content

Navigation group

Type at least 3 characters
1,300 articles

Articles

Original Research

Published on 07 Jun 2024

A two-years real-word study with fingolimod: early predictors of efficacy and an association between EBNA-1 IgG titers and multiple sclerosis progression

in Multiple Sclerosis and Neuroimmunology

  • Maria Inmaculada Dominguez-Mozo
  • Victoria Galán
  • Lluís Ramió-Torrentà
  • Ana Quiroga
  • E. Quintana
  • Luisa María Villar
  • Lucienne Costa-Frossard
  • José Ignacio Fernández-Velasco
  • Noelia Villarrubia
  • María Angel Garcia-Martinez
A two-years real-word study with fingolimod: early predictors of efficacy and an association between EBNA-1 IgG titers and multiple sclerosis progression
Frontiers in Immunology
doi 10.3389/fimmu.2024.1384411
  • 1,291 views